Sandoz Group AG (SDZNY)
OTCMKTS · Delayed Price · Currency is USD
59.80
+1.03 (1.76%)
Sep 16, 2025, 3:59 PM EDT
Sandoz Group AG Revenue
Sandoz Group AG had revenue of $5.27B in the half year ending June 30, 2025, with 6.80% growth. This brings the company's revenue in the last twelve months to $10.59B, up 4.71% year-over-year. In the year 2024, Sandoz Group AG had annual revenue of $10.38B with 4.06% growth.
Revenue (ttm)
10.59B
Revenue Growth
+4.71%
P/S Ratio
2.42
Revenue / Employee
529.35K
Employees
22,049
Market Cap
25.65B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10.38B | 405.00M | 4.06% |
Dec 31, 2023 | 9.98B | 673.00M | 7.23% |
Dec 31, 2022 | 9.31B | -372.00M | -3.84% |
Dec 31, 2021 | 9.68B | 20.00M | 0.21% |
Dec 31, 2020 | 9.66B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Tian'an Technology Group | 2.12M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
AMJ Global Technology | 39.00 |
Sandoz Group AG News
- 7 days ago - Regeneron (REGN) Reaches Settlement with Sandoz Over Eylea Biosimilar - GuruFocus
- 20 days ago - Sandoz welcomes Quebec government support for Boucherville plant modernization project - Benzinga
- 5 weeks ago - Lupin partners with Sandoz to commercialize Ranibizumab biosimilar in multiple global markets - Business Upturn
- 5 weeks ago - Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations - GlobeNewsWire
- 5 weeks ago - Sandoz Group AG 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 5 weeks ago - Sandoz Group AG (SDZNY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarter - GlobeNewsWire
- 6 weeks ago - Sandoz targets 70% price cut for weight-loss drugs in Canada, FT reports - Reuters